American Medical Optic’s (AMO) iLasik procedure is now available in New Jersey by Dr. Daniel Goldberg. iLASIK is a proprietary procedure performed on AMO’s leading technology platform which combines WaveScan, Intralase, and VISX S4 with iris registration.  The new iLasik procedure integrates the very best in Lasik related techology to deliver optimal results for New Jersey Lasik candidates.

Dr. Daniel B Goldberg, Director of Refractive/LASIK Surgery, at The Atlantic Laser Vision Center in Little Silver, NJ  has a long-standing commitment to providing the most advanced technology for all his procedures, and that’s a great asset for potential patients.  Dr. Goldberg has completed over 10,000 Lasik procedures in New Jersey and a top choice for lasik eye surgery in the state.

Under Dr. Goldberg’s leadership, the Atlantic Laser Vision Center in Little Silver has continued to upgrade its lasers to provide the latest technologies and the best results.  The facility is the first in New Jersey, and one of the first in the US to combine the Intralase Femtosecond all-laser, no-blade flap with the VISX customized Excimer laser platform. 

“Our system now has been revised to integrate all of the new technology,” Goldberg says, “we have continued to bring the very best LASIK technologies to New Jersey which benefits our patients with safer and more accurate results.”  The the latest addition of iris registration theVISX S4 registers the treatment more accurately while delivering more precise customized treatment.  

The new AMO technologies qualify the facility as one of only a few centers in New Jersey certified to perform iLASIK.  iLASIK is a proprietary procedure performed on American Medical Optic’s (AMO) best equipment—WaveScan, Intralase, and VISX S4 with iris registration and FDA approved custom monovision.  In 2007 the FDA approved customVue monovision, which is part of the iLASIK platform.  Now all of these technologies—WaveScan, Intralase, VISX S4, and CustomVue monovision have been combined by AMO as iLASIK.  As further evidence of the advantages of this technology, the US Air Force, US Navy, and NASA have chosen the iLASIK platform for their pilots and astronauts.  All of these major advancements will result in safer, more exact laser vision correction results for patients at the Atlantic Laser Center in Little Silver, New Jersey.  

Dr. Goldberg helped introduce the use of IntraLase® in New Jersey, knowing it represented an extraordinary leap in refractive surgery. IntraLase® is more precise and safe than a microkeratome, or mechanical blade, in the critical first step of LASIK: creating the corneal flap. Replacing the microkeratome with IntraLase® gives LASIK patients a critical added safety factor.  Now, New Jersey LASIK patients have a safer, more precise alternative to the tiny handheld blade used by most to create the flap.

If you would like to schedule a consultation with Dr. Goldberg, please contact Gail Cerone our Laser Vision Coordinator .  You can reach Gail at 866-853-3263 or via email at gailcer1@gmail.com

Dr Daniel Goldberg, a pioneer in Laser eye surgery and the director of vision correction at the Atlantic Laser Vision Center was awarded ‘Top Doctor” by Castle Connolly Medical.

Castle Connolly Medical Ltd. is a healthcare research and information company founded in 1991. Their goal is to help guide consumers to America’s top doctors and top hospitals using a detailed survey and comprehensive research

Dr Goldberg’s award recognizes him as one of the best doctors in the field of Ophthalmology. Dr Goldberg is credited as one of the first laser eye surgeons to help bring advanced technologies in the field to the United States. Dr. Daniel Goldberg has a rare dual certification from both the Council for Refractive Surgery Quality Assurance (an independent, nonprofit, patient and consumer health organization that evaluates and verifies the quality of the surgeries provided by select refractive surgeons in the United States), and the ABES( American Board of Eye Surgeons ). Nationwide, there are less than 10 LASIK surgeons with dual certification by ABES and CRSQA.

Dr Goldberg was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK. In 2000, at the ASCRS(American Society of Cataract and Refractive Surgeons) national meeting, the first large scale study of LASIK monovision was presented by Goldberg and the published paper appeared in 2001 in the Journal of Cataract and Refractive Surgery. Further research by Goldberg resulted in another large study of LASIK monovision which was published in 2003—this work compared results in far-sighted eyes as well as near-sighted eyes. Based on this research, Goldberg made presentations at national meetings on “Succeeding with LASIK Monovision” and taught courses at the ASCRS meetings on “Surgical correction of Presbyopia.”

In April of 2008, Dr Goldberg was recognized at the inaugural training session for Custom Vue Monovision in Chicago for helping to set the stage for the FDA approval of LASIK monovision.

For more information, visit www.goldberg4lasik.com

Dr. Daniel Goldberg, a laser eye surgeon and director of laser eye surgery at the Atlantic Laser Vision Center has been named to the 2009-2010 Best Doctors in America.  A peer review survey by thousands of doctors determines which physicians are included.  Since doctors cannot buy listings in the directory, being selected is an exclusive honor for medical professionals.

Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  He was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK.  

Dr Goldberg has 25 years of experience in refractive surgery and has performed over 10,000 LASIK surgery procedures.  He recently became the first New Jersey eye surgeon to use the implantable contact lens (ICL) – a new technology to correct nearsightedness in individuals with extremely high prescriptions. 

In 2008, Dr Goldberg was also recently honored by Castle Connolly Medical who presented him with their annual ‘Top Doctor” award which recognizes him as one of the best doctors in the field of Ophthalmology.  Then, in April of 2008, Dr Goldberg was again recognized at the inaugural training session for Custom Vue Monovision in Chicago for helping to set the stage for the FDA approval of LASIK monovision.

Dr Goldberg is constantly on the forefront of groundbreaking technology and innovations in the field of Ophthalmology.  Currently Dr Goldberg is leading a worldwide study testing the effectiveness of using 5% Betadine irrigation for the treatment of acute EKC- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement.  Ophthalmologists around the world are invited to register to participate in the Betadine for EKC study and can do so by visiting http://www.betadineforekc.com/submission-process.aspx.   

More information on Dr Daniel Goldberg is available at http://www.goldberg4lasik.com/